Related Experiment Video

Updated: Jun 20, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Molecular mechanisms of congenital heart disease

Jing-bin Huang1, Ying-long Liu, Pei-wu Sun

  • 1Pediatric Center of Cardiac Surgery, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|September 15, 2009
PubMed

Insights

Congenital heart disease (CHD) is a common birth defect with unknown causes for most cases. Research is uncovering genetic factors and molecular mechanisms, offering hope for better genetic counseling and care.

Area of Science:

  • Cardiology
  • Genetics
  • Developmental Biology

Background:

  • Congenital heart disease (CHD) represents the most prevalent birth defect.
  • Despite advancements in cardiac development understanding and gene identification, the primary etiology for most CHD cases remains elusive.

Purpose of the Study:

  • To review normal cardiac development.
  • To outline recent genetic discoveries in CHD etiology.
  • To propose strategies for further investigation of CHD causes.

Main Methods:

  • Literature review of cardiac development.
  • Analysis of recent genetic findings in congenital heart defects.
  • Synthesis of potential research strategies for CHD etiology.

Main Results:

  • CHD is a complex, multifactorial disease influenced by environmental and genetic factors.
  • Specific causative genes for certain congenital heart defects and genetic syndromes have been identified.
  • Potential molecular mechanisms include gene network mutations, altered hemodynamics, gene regulation, micro-RNA dysfunction, and epigenetics.

Conclusions:

  • The molecular basis of CHD is a dynamic and rapidly advancing field.
  • Continued progress in understanding CHD molecular mechanisms is expected to enhance genetic counseling and patient care.
Abstract

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography08:01

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Published on: November 22, 2013

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...